[A new highly effective therapy of indolent non-Hodgkin lymphomas with bendamustin].
D000818:Animals; D001317:Austria; D000069461:Bendamustine Hydrochloride; D005858:Germany; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy* / Q000401:mortality; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D015996:Survival Rate; D016896:Treatment Outcome
D009588:Nitrogen Mustard Compounds; D000069461:Bendamustine Hydrochloride